Endothelial nitric oxide synthase gene T−786C and 27-bp repeat gene polymorphisms in retinopathy of prematurity

Purpose Retinopathy of prematurity (ROP), which is associated with abnormal retinal vessel development, is the leading cause of visual loss in preterm infants. Endothelial nitric oxide synthase (eNOS) is believed to play a central role in both retinal angiogenesis and vasculogenesis. The aim of this study was to investigate functional genetic polymorphisms of eNOS in the pathogenesis of ROP. Methods eNOS T−786C and 27-bp repeat (eNOS, b: wild-type, a: mutant) genotypes were determined using allele-specific polymerase chain reaction in 105 low birth weight (LBW) preterm infants treated for ROP (treated group). A control group was set up and composed of 127 LBW infants with stage 1 or 2 ROP that did not not require treatment (untreated group). Results The genotype distribution of eNOS 27-bp repeat polymorphism was found to significantly differ (p=0.015) between the two groups, whereas the genotype distribution of eNOS T−786C did not differ (p=0.984) between the groups. There was no difference in the distribution of either the “a” allele (p=0.153) nor of the C allele (p=0.867) in a groups comparison. Multiple logistic regression analysis revealed that male gender (p=0.046) and eNOS aa genotype (p=0.047 versus ab genotype and p=0.022 versus bb genotype) were significantly associated severe ROP that required treatment. The haplotype estimations based on the detected genotype distributions showed that the prevalence of aT and bT haplotypes was significantly increased in the group treated for ROP. Conclusions Functional eNOS 27-bp repeat polymorphism might be associated with the risk of severe ROP, however we found no association between the eNOS T−786C and the pathogenesis of ROP.

[1]  J. Tanus-Santos,et al.  Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. , 2006, Nitric oxide : biology and chemistry.

[2]  R. Kim,et al.  Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. , 2006, Molecular vision.

[3]  G. Slama,et al.  The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. , 2005, Nitric oxide : biology and chemistry.

[4]  L. Cubeddu,et al.  Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics , 2005, Journal of Human Hypertension.

[5]  P. Hardy,et al.  Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. , 2004, Free radical biology & medicine.

[6]  K. Inukai,et al.  Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. , 2004, Diabetes care.

[7]  Rongling Li,et al.  Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. , 2004, American journal of hypertension.

[8]  Leh Smith.  Pathogenesis of retinopathy of prematurity , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[9]  R. Caldwell,et al.  Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. , 2003, American journal of physiology. Cell physiology.

[10]  Christina Gloeckner,et al.  Modern Applied Statistics With S , 2003 .

[11]  H. Esumi,et al.  Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. , 2003, Acta biochimica Polonica.

[12]  J. Cooke,et al.  Nitric oxide and angiogenesis. , 2002, Circulation.

[13]  P. Campochiaro,et al.  Nitric oxide is proangiogenic in the retina and choroid * , 2002, Journal of cellular physiology.

[14]  Shotai Kobayashi,et al.  T-786C Polymorphism in Endothelial NO Synthase Gene Affects Cerebral Circulation in Smokers: Possible Gene-Environmental Interaction , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. Slama,et al.  eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[16]  P. Huang,et al.  Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. , 2001, Investigative ophthalmology & visual science.

[17]  P. Campochiaro,et al.  Retinal and choroidal neovascularization , 2000, Journal of cellular physiology.

[18]  S. Mousa,et al.  Antiangiogenesis efficacy of nitric oxide donors , 2000, Journal of cellular biochemistry.

[19]  J. Clive,et al.  Current Incidence of Retinopathy of Prematurity, 1989–1997 , 1999, Pediatrics.

[20]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[21]  H. Itoh,et al.  Endothelial nitric oxide synthase gene is positively associated with essential hypertension. , 1998, Hypertension.

[22]  Y. Kawaguchi,et al.  Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. , 1998, Biochemical and biophysical research communications.

[23]  S. Gross,et al.  Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.

[24]  F. Wong,et al.  T-cell receptor constant beta chain polymorphisms and susceptibility to type 1 diabetes. , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[25]  W. Silverman.  Retrolental Fibroplasia: A Modern Parable , 1980 .